{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:27Z","timestamp":1707525687918},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,3]]},"DOI":"10.7759\/cureus.51617","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:28:53Z","timestamp":1704342533000},"source":"Crossref","is-referenced-by-count":0,"title":["Radiation Therapy for Breast Cancer With Oligometastatic Cervical Lymph Nodes: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Burioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unta","family":"Yamamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihisa","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman S","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995, 13:8-10. 10.1200\/JCO.1995.13.1.8","journal-title":"J Clin Oncol"},{"key":"ref2","unstructured":"FRQ6 is stereotactic body radiotherapy recommended for a few metastases\/recurrence?. (2022). https.\/\/jbcs.xsrv.jp\/guideline\/2022\/h_index\/frq6\/."},{"key":"ref3","unstructured":"Review vs. metastatic\/recurrent breast cancer. (2022). https.\/\/jbcs.xsrv.jp\/guideline\/2022\/s\/s5\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2015.35.e8","article-title":"Surgery or ablative radiotherapy for breast cancer oligometastases","author":"Salama JK","year":"2015","unstructured":"Salama JK, Chmura SJ. Surgery or ablative radiotherapy for breast cancer oligometastases. Am Soc Clin Oncol Educ Book. 2015, 8-15. 10.14694\/EdBook_AM.2015.35.e8","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1128","article-title":"Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review","volume":"10","author":"Kent CL","year":"2021","unstructured":"Kent CL, McDuff SG, Salama JK. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review. Ann Palliat Med. 2021, 10:5954-68. 10.21037\/apm-20-1128","journal-title":"Ann Palliat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S176763","article-title":"Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study","volume":"10","author":"Xiao W","year":"2018","unstructured":"Xiao W, Zheng S, Yang A, Zhang X, Zou Y, Tang H, Xie X. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study. Cancer Manag Res. 2018, 10:5329-38. 10.2147\/CMAR.S176763","journal-title":"Cancer Manag Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0918-8","article-title":"Supraclavicular recurrence after early breast cancer: a curable condition?","volume":"125","author":"Pedersen AN","year":"2011","unstructured":"Pedersen AN, M\u00f8ller S, Steffensen KD, et al.. Supraclavicular recurrence after early breast cancer: a curable condition?. Breast Cancer Res Treat. 2011, 125:815-22. 10.1007\/s10549-010-0918-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14748\/vmf.v12i1.9034","article-title":"Lymph nodes of the head and neck: in normal and pathological conditions","volume":"12","author":"Nikolaev NN","year":"2023","unstructured":"Nikolaev NN, Yankov YG. Lymph nodes of the head and neck: in normal and pathological conditions. Varna Med Forum. 2023, 12:69-74. 10.14748\/vmf.v12i1.9034","journal-title":"Varna Med Forum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.134.5.536","article-title":"Consensus statement on the classification and terminology of neck dissection","volume":"134","author":"Robbins KT","year":"2008","unstructured":"Robbins KT, Shaha AR, Medina JE, et al.. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008, 134:536-8. 10.1001\/archotol.134.5.536","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050381","article-title":"Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer","volume":"26","author":"Boerner AR","year":"1999","unstructured":"Boerner AR, Weckesser M, Herzog H, et al.. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med. 1999, 26:226-30. 10.1007\/s002590050381","journal-title":"Eur J Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2012.02.003","article-title":"Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity","volume":"42","author":"Schillaci O","year":"2012","unstructured":"Schillaci O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin Nucl Med. 2012, 42:267-80. 10.1053\/j.semnuclmed.2012.02.003","journal-title":"Semin Nucl Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.06.1901","article-title":"Patterns of distant failure and progression in breast cancer: implications for the treatment of oligometastatic disease","volume":"81","author":"Dorn PL","year":"2011","unstructured":"Dorn PL, Meriwether A, LeMieux M, Weichselbaum RR, Chmura SJ, Hasan Y. Patterns of distant failure and progression in breast cancer: implications for the treatment of oligometastatic disease. Int J Radiat Oncol Biol Phys. 2011, 81:10.1016\/j.ijrobp.2011.06.1901","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein HJ","year":"2021","unstructured":"Burstein HJ, Curigliano G, Th\u00fcrlimann B, et al.. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021, 32:1216-35. 10.1016\/j.annonc.2021.06.023","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0157-4","article-title":"Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy","volume":"115","author":"Milano MT","year":"2009","unstructured":"Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat. 2009, 115:601-8. 10.1007\/s10549-008-0157-4","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.08.032","article-title":"Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial","volume":"126","author":"Trovo M","year":"2018","unstructured":"Trovo M, Furlan C, Polesel J, et al.. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. Radiother Oncol. 2018, 126:177-80. 10.1016\/j.radonc.2017.08.032","journal-title":"Radiother Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5027457","article-title":"Exploring the prognosis of breast cancer with synchronous distant nonregional lymph node metastasis and establishing a predictive model: a population-based study","volume":"2022","author":"Lin H","year":"2022","unstructured":"Lin H, Lin J, Wu Y, Liang G, Sun J, Chen L. Exploring the prognosis of breast cancer with synchronous distant nonregional lymph node metastasis and establishing a predictive model: a population-based study. Biomed Res Int. 2022, 2022:10.1155\/2022\/5027457","journal-title":"Biomed Res Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.10086","article-title":"Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes","volume":"52","author":"Kodani N","year":"2011","unstructured":"Kodani N, Yamazaki H, Tsubokura T, et al.. Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res. 2011, 52:24-31. 10.1269\/jrr.10086","journal-title":"J Radiat Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.04.027","article-title":"Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors","volume":"81","author":"Cengiz M","year":"2011","unstructured":"Cengiz M, \u00d6zyi\u011fit G, Yazici G, et al.. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2011, 81:104-9. 10.1016\/j.ijrobp.2010.04.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.11.045","article-title":"Carotid dosimetry and the risk of carotid blowout syndrome after reirradiation with head and neck stereotactic body radiation therapy","volume":"101","author":"Gebhardt BJ","year":"2018","unstructured":"Gebhardt BJ, Vargo JA, Ling D, et al.. Carotid dosimetry and the risk of carotid blowout syndrome after reirradiation with head and neck stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2018, 101:195-200. 10.1016\/j.ijrobp.2017.11.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2020.23.e14","article-title":"Cervical lymph node involvement above the supraclavicular fossa in breast cancer: comparison with stage IIIC (KROG 18-02)","volume":"23","author":"Kim JS","year":"2020","unstructured":"Kim JS, Kim K, Shin KH, et al.. Cervical lymph node involvement above the supraclavicular fossa in breast cancer: comparison with stage IIIC (KROG 18-02). J Breast Cancer. 2020, 23:194-204. 10.4048\/jbc.2020.23.e14","journal-title":"J Breast Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/210668-radiation-therapy-for-breast-cancer-with-oligometastatic-cervical-lymph-nodes-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:48Z","timestamp":1707509628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/210668-radiation-therapy-for-breast-cancer-with-oligometastatic-cervical-lymph-nodes-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.51617","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,3]]}}}